Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches Life Science Investing
ARS Pharmaceuticals Reports First Quarter 2026 Financial Results and Corporate Update Life Science Investing
Ocugen, Inc. Announces Closing for $130.0 Million of 6.75% Convertible Senior Notes Life Science Investing
HCW Biologics Reports First Quarter 2026 Business Highlights and Financial Results Life Science Investing
Tempest Reports First Quarter 2026 Financial Results and Provides Business Update Life Science Investing
RenovoRx Reports Record First Quarter 2026: Increasing Revenue by 136% Quarter-over-Quarter Life Science Investing
Nurix Therapeutics Presents New Preclinical and Phase 1 Translational Data Supporting Bexobrutideg in Chronic Spontaneous Urticaria at the 2026 Society for Investigative Dermatology Annual Meeting Life Science Investing
